Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sandra Bibbò"'
Autor:
Pierpaolo Di Martino, Valentina Marcozzi, Sandra Bibbò, Barbara Ghinassi, Angela Di Baldassarre, Giulia Gaggi, Andrea Di Credico
Publikováno v:
Brain Sciences, Vol 14, Iss 6, p 553 (2024)
Parkinson’s disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) are examples of neurodegenerative movement disorders (NMDs), which are defined by a gradual loss of motor function that is frequently accompanied by cognitiv
Externí odkaz:
https://doaj.org/article/2f985e22ccb444b9948ca36a2833ad22
Autor:
Alexia Tsakaneli, Victor Corasolla Carregari, Martina Morini, Alessandra Eva, Giuliana Cangemi, Olesya Chayka, Evgeny Makarov, Sandra Bibbò, Emily Capone, Gianluca Sala, Vincenzo De Laurenzi, Evon Poon, Louis Chesler, Luisa Pieroni, Martin R. Larsen, Giuseppe Palmisano, Arturo Sala
Publikováno v:
Open Biology, Vol 11, Iss 12 (2021)
Amplification of the proto-oncogene MYCN is a key molecular aberration in high-risk neuroblastoma and predictive of poor outcome in this childhood malignancy. We investigated the role of MYCN in regulating the protein cargo of extracellular vesicles
Externí odkaz:
https://doaj.org/article/12d0e9b553254367b95d2b65de857eae
Autor:
Beatrice Dufrusine, Silvia Valentinuzzi, Sandra Bibbò, Verena Damiani, Paola Lanuti, Damiana Pieragostino, Piero Del Boccio, Ersilia D’Alessandro, Alberto Rabottini, Alessandro Berghella, Nerino Allocati, Katia Falasca, Claudio Ucciferri, Francesco Mucedola, Marco Di Perna, Laura Martino, Jacopo Vecchiet, Vincenzo De Laurenzi, Enrico Dainese
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 1; Pages: 15
Coronavirus disease 2019 (COVID-19) is characterized by a broad spectrum of clinical symptoms. After acute infection, some subjects develop a post-COVID-19 syndrome known as long-COVID. This study aims to recognize the molecular and functional mechan
Autor:
Luisa Pieroni, Giuseppe Palmisano, Gianluca Sala, Martina Morini, Evon Poon, Arturo Sala, Louis Chesler, Alessandra Eva, Alexia Tsakaneli, Vincenzo De Laurenzi, Evgeny M. Makarov, Martin R. Larsen, Giuliana Cangemi, Sandra Bibbò, Emily Capone, Olesya Chayka, Victor Corasolla Carregari
Publikováno v:
Tsakaneli, A, Carregari, V C, Morini, M, Eva, A, Cangemi, G, Chayka, O, Makarov, E, Bibbò, S, Capone, E, Sala, G, De Laurenzi, V, Poon, E, Chesler, L, Pieroni, L, Larsen, M R, Palmisano, G & Sala, A 2021, ' MYC regulates metabolism through vesicular transfer of glycolytic kinases ', Open Biology, vol. 11, no. 12, 210276 . https://doi.org/10.1098/rsob.210276
Open Biology
Open Biology, Vol 11, Iss 12 (2021)
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Open Biology
Open Biology, Vol 11, Iss 12 (2021)
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Electronic supplementary material is available online at https://doi.org/10.6084/m9.figshare.c.5713034. Copyright © 2021 The Authors. Amplification of the proto-oncogene MYCN is a key molecular aberration in high-risk neuroblastoma and predictive of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa9b97ab242ebbd2923beab216db9653
https://findresearcher.sdu.dk:8443/ws/files/197558028/rsob.210276.pdf
https://findresearcher.sdu.dk:8443/ws/files/197558028/rsob.210276.pdf
Autor:
Liborio Stuppia, Simone De Fabritiis, Fabrizio Di Giuseppe, Vincenzo De Laurenzi, Sandra Bibbò, Domitilla Mandatori, Carola Di Camillo, Carlotta Buccolini, Anna Giulia Ruggieri, Rossella Ferrante, Verena Damiani, Paolo Fazii, Dora Pizzi
Publikováno v:
Infection Control and Hospital Epidemiology
Autor:
Manuela Iezzi, Sandra Bibbò, Alexia Tsakaneli, Paolo Ciufici, Gianluca Sala, Arturo Sala, Alessia Lamolinara, Emily Capone, Stefania Purgato, Valeria Panella, Michele Sallese, Vincenzo De Laurenzi, Giovanni Perini, Cosmo Rossi, Valentina Nieddu
Publikováno v:
Oncogenesis
Oncogenesis, Vol 9, Iss 1, Pp 1-8 (2020)
Oncogenesis, Vol 9, Iss 1, Pp 1-8 (2020)
The MYC family of transcription factors is a major driver of human cancer and potential therapeutic target. However, no clinically viable drugs have been yet developed that are able to directly tackle MYC oncoproteins. In our laboratory, we are explo
Autor:
Vincenzo De Laurenzi, Manuela Iezzi, Fabio Pastorino, Rodolfo Ippoliti, Rossano Lattanzio, Stefano Iacobelli, Enza Piccolo, Valeria Panella, Sara Ponziani, Michele Sallese, Mirco Ponzoni, Cosmo Rossi, Giulia Di Vittorio, Francesco Giansanti, Arturo Sala, Gianluca Sala, Daniela D'Agostino, Valentina Iacobelli, Sandra Bibbò, Alessia Lamolinara, Emily Capone, Roberta Gentile
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2989, p 2989 (2020)
Volume 12
Issue 10
Cancers, Vol 12, Iss 2989, p 2989 (2020)
Volume 12
Issue 10
Simple Summary Antibody Drug Conjugates are an emerging class of biopharmaceuticals that have seen an impressive increase of attention in the field of cancer therapy. Here, we describe the therapeutic activity of 1959-sss/DM3, a non-internalizing ADC
Autor:
Giulio Fracasso, Elisabetta Falvo, Giada Tisci, Gianluca Sala, Gianni Colotti, Sara Cingarlini, Claudia Tito, Sandra Bibbo, Cristina Frusteri, Elisa Tremante, Elena Giordani, Patrizio Giacomini, Pierpaolo Ceci
Publikováno v:
Heliyon, Vol 9, Iss 10, Pp e20770- (2023)
Background: Cancer is still among the leading causes of death all over the world. Improving chemotherapy and minimizing associated toxicities are major unmet medical needs. Recently, we provided a preliminary preclinical evaluation of a human ferriti
Externí odkaz:
https://doaj.org/article/25b7226ed4974a9dbaadcf2acec008ae
Autor:
Emily Capone, Sara Ponziani, Francesco Giansanti, Roberta Gentile, Giulia Di Vittorio, Vincenzo De Laurenzi, Michele Sallese, Sandra Bibbò, Arturo Sala, Rodolfo Ippoliti, Jean Frederic Sauniere, Stefano Iacobelli, Gianluca Sala
Publikováno v:
Cancer Research. 79:238-238
Neuroblastoma is a solid tumour affecting the peripheral nervous system accounting for ∼13% of all pediatric cancer mortality. Despite immunotherapy with the GD2 antibody has improved the clinical outcome of a fraction of patients with metastatic n